Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Director Declaration

14th Dec 2023 12:30

RNS Number : 8704W

Dechra Pharmaceuticals PLC

14 December 2023

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

DIRECTOR DECLARATION

In accordance with Listing Rule 9.6.14(2) Dechra announces that Alison Platt, Non-Executive Chair of Dechra, has been appointed as a Non-Executive Director of Inchcape plc. Alison will join the Board of Inchcape plc on 2 January 2024.

For further information, please contact:

Dechra Pharmaceuticals PLC

Telephone number: +44 (0) 1606 814730

Email: [email protected]

About Dechra

Dechra is a global veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information, please visit: www.dechra.com.

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNTIBTTMTTBBLJ

Related Shares:

FTSE 100 Latest

Value8,809.74

Change53.53